Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | WO2002012553A3 Method for detecting mutations in nucleotide sequences |
01/30/2003 | WO2002010362A3 Methods of controlling gene expression and gene silencing |
01/30/2003 | WO2002009865A1 Production of polyelectrolyte capsules by surface precipitation |
01/30/2003 | WO2002004491A3 Methods and compositions relating to muscle selective calcineurin interacting protein (mcip) |
01/30/2003 | WO2001094566A3 Human enzymes and polynucleotides encoding the same |
01/30/2003 | WO2001088113A3 Hepatitis c virus helicase crystals, crystallographic structure and methods |
01/30/2003 | WO2001081589A3 14911 novel protein kinase molecules and uses therefor |
01/30/2003 | WO2001079488A3 14257,protein kinase molecules and uses therefor |
01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
01/30/2003 | WO2001077161A3 Gtp binding stress-related proteins and methods of use in plants |
01/30/2003 | US20030024012 Transgenic plant for use as tool in the generation of mammalian proteins |
01/30/2003 | US20030024011 Plant oils with altered oleic acid content |
01/30/2003 | US20030024010 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation |
01/30/2003 | US20030024009 Genetically engineered plants for use as animal nutrients |
01/30/2003 | US20030024000 Animal models for use in the treatment of injuries and psoriasis |
01/30/2003 | US20030023990 Jnk3 modulators and methods of use |
01/30/2003 | US20030023065 Novel human ATPase proteins and polynucleotides encoding the same |
01/30/2003 | US20030023064 Novel human phosphatases and polynucleotides encoding the same |
01/30/2003 | US20030023063 Novel human kinases and polynucleotides encoding the same |
01/30/2003 | US20030023062 For diagnosis, drug screening, clinical trial monitoring, the therapy of physiological disorders or infectious disease |
01/30/2003 | US20030023060 For diagnosis, drug screening, clinical trial monitoring, the treatment of diseases |
01/30/2003 | US20030023055 For use in cancer therapy |
01/30/2003 | US20030023054 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030023036 Drugs, vaccines |
01/30/2003 | US20030023034 p27 (Kip1) -FKBP-12 protein complexes |
01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
01/30/2003 | US20030022870 Methods of treating cardiac disorders |
01/30/2003 | US20030022857 Mitogen-activated protein (MAP) kinase phosphatase (MKP) for use in metabolic disorders; gene expression; genetic engineering; diagnosis |
01/30/2003 | US20030022853 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
01/30/2003 | US20030022844 Hydrolyzing lactose to galactose and glucose and isomerizing galactose to tagatose and chromatographic separation and recycling any unconverted compounds |
01/30/2003 | US20030022807 Xyloglucanases belonging to family 5 of glycosyl hydrolases are derived from strains of paenibacillus, the xyloglucanases show high performance in conventional liquid detergent |
01/30/2003 | US20030022371 Antifreeze polypeptides for use in prefeation of frozen foods |
01/30/2003 | US20030022354 Protein c derivatives |
01/30/2003 | US20030022353 Protein for use in the treatment of nervous system disorders |
01/30/2003 | US20030022351 Alkaline proteases |
01/30/2003 | US20030022350 Enzymatic polypeptide for use in the prevention of thrombosis |
01/30/2003 | US20030022348 Modified forms of pullulanase |
01/30/2003 | US20030022347 Bacterial galactanases and use thereof |
01/30/2003 | US20030022346 Enzymatic polypeptide for use in detergents, textile processing and papermaking |
01/30/2003 | US20030022344 Enzymatic polypeptide for use in monitoring and controlling signal transduction in proliferating cells |
01/30/2003 | US20030022343 Inositolphosphoryl ceramide (IPC) synthase genes from fungi |
01/30/2003 | US20030022342 Inositolphosphoryl ceramide (IPC) synthase genes from fungi |
01/30/2003 | US20030022341 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
01/30/2003 | US20030022340 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
01/30/2003 | US20030022339 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | US20030022337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | US20030022336 Enzymatic polypeptide for use in the diagnosis of diabetes |
01/30/2003 | US20030022335 Novel polypeptides and methods for their use |
01/30/2003 | US20030022334 33312, 33303, 32579, novel human cytochrome P450 family members and uses thereof |
01/30/2003 | US20030022333 Preservation of samples by dehydration; obtain sample, dry, cool and store on shell |
01/30/2003 | US20030022331 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022328 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022323 Generation of 1,3-propanediol; obtain microorganism, transform with vector, propagate in nutrient broth, express vector, recover propanediol |
01/30/2003 | US20030022322 SAM operon |
01/30/2003 | US20030022320 Nucleic acid sequences coding polypeptide for use in the generation of preferential amino acids, for use in animal nutrients, pharmocology and medicines |
01/30/2003 | US20030022308 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
01/30/2003 | US20030022307 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
01/30/2003 | US20030022306 Polypeptide for use in the treatment of cancer |
01/30/2003 | US20030022281 Kluyveromyces lactis maltase/maltose permease bi-directional promoter and use thereof |
01/30/2003 | US20030022273 Fermentative carotenoid production |
01/30/2003 | US20030022241 Detection of modulators of enzyme activity; obtain sample containing kinase activity, incubate with modulator, monitor diabetic response |
01/30/2003 | US20030022232 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis |
01/30/2003 | US20030022229 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
01/30/2003 | US20030022212 65649, a human metalloprotease family member and uses therefor |
01/30/2003 | US20030022201 68999, a human ubiquitin carboxyl-terminal hydrolase family member and uses therefor |
01/30/2003 | US20030022187 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
01/30/2003 | US20030022185 Secreted protein HLHFP03 |
01/30/2003 | US20030022180 Nucleotide sequences coding enzymatic polypeptide for use in the diagnosis and treatment of cell proliferation disorders |
01/30/2003 | US20030022178 Identification of sortase gene |
01/30/2003 | US20030022168 Nucleotide sequences coding enzymatic polypeptide for use in prevention of braest cancer |
01/30/2003 | US20030021802 Genetic engineering; diagnosing gastrointestinal disorders |
01/30/2003 | US20030021799 Adjustment pH; mixture containing polymerase chain reactions |
01/30/2003 | US20030021784 33200, a novel human dehydrogenase/reductase family member and uses thereof |
01/30/2003 | US20030021774 Adjusting nutrient in animal feeds |
01/30/2003 | CA2454873A1 Novel transformed cell, method for screening anti-aging agent, and anti-aging agent |
01/30/2003 | CA2454563A1 Glucans and glucansucrases derived from lactic acid bacteria |
01/30/2003 | CA2454548A1 Process for obtaining growth factor (tgf-beta and igf-1), lactoperoxidase and immunoglobulins preparations from milk products having low mutual cross-contamination |
01/30/2003 | CA2454419A1 Invasion complex and methods of targeting |
01/30/2003 | CA2454189A1 High protein, bowman-birk inhibitor concentrate and process for its manufacture |
01/30/2003 | CA2452832A1 .gamma.-secretase in vitro screening assay |
01/30/2003 | CA2452322A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
01/30/2003 | CA2451607A1 A thermostable isomerase and use thereof in particular for producing tagatose |
01/30/2003 | CA2450692A1 Tumor antigen |
01/29/2003 | EP1279744A2 Identification and use of molecules implicated in pain |
01/29/2003 | EP1279736A1 Methods of RNA and protein synthesis |
01/29/2003 | EP1279332A2 Transgenic non-human mammal |
01/29/2003 | EP1278886A2 Sigma binding region of rna polymerase and uses thereof |
01/29/2003 | EP1278881A1 Hybrid glycosylated products and their production and use |
01/29/2003 | EP1278876A2 STABLE i ZYMOMONAS MOBILIS /i XYLOSE AND ARABINOSE FERMENTING STRAINS |
01/29/2003 | EP1278873A1 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp |
01/29/2003 | EP1278872A1 Novel plant glucosidase i and use thereof for producing recombinant proteins with modified glycosylation |
01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
01/29/2003 | EP1278870A1 Splice variant of camp phosphodiesterase type 7 (pde7a3) |
01/29/2003 | EP1278869A2 Proteases |
01/29/2003 | EP1278868A2 Novel mutated form of arginine deiminase |
01/29/2003 | EP1278867A2 Hcv ns2/3 fragments and uses thereof |
01/29/2003 | EP1278866A2 Serine-threonine kinase |
01/29/2003 | EP1278865A1 Nucleotide sequences which code for the pgsa2 gene |
01/29/2003 | EP1278864A2 Serine-threonine kinase-3 |